These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Integrin-linked kinase expression is elevated in human cardiac hypertrophy and induces hypertrophy in transgenic mice. Lu H; Fedak PW; Dai X; Du C; Zhou YQ; Henkelman M; Mongroo PS; Lau A; Yamabi H; Hinek A; Husain M; Hannigan G; Coles JG Circulation; 2006 Nov; 114(21):2271-9. PubMed ID: 17088456 [TBL] [Abstract][Full Text] [Related]
8. Calcineurin activation is not necessary for Doxorubicin-induced hypertrophy in H9c2 embryonic rat cardiac cells: involvement of the phosphoinositide 3-kinase-Akt pathway. Merten KE; Jiang Y; Feng W; Kang YJ J Pharmacol Exp Ther; 2006 Nov; 319(2):934-40. PubMed ID: 16926266 [TBL] [Abstract][Full Text] [Related]
9. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth. Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416 [TBL] [Abstract][Full Text] [Related]
10. Signaling pathways activated by vasoactive peptides in the cardiac myocyte and their role in myocardial pathologies. Sugden PH J Card Fail; 2002 Dec; 8(6 Suppl):S359-69. PubMed ID: 12555146 [TBL] [Abstract][Full Text] [Related]
11. Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy. Li HL; Yin R; Chen D; Liu D; Wang D; Yang Q; Dong YG J Cell Biochem; 2007 Apr; 100(5):1086-99. PubMed ID: 17266062 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin II induced upregulation of G alpha q/11, phospholipase C beta 3 and extracellular signal-regulated kinase 1/2 via angiotensin II type 1 receptor. Bai H; Wu LL; Xing DQ; Liu J; Zhao YL Chin Med J (Engl); 2004 Jan; 117(1):88-93. PubMed ID: 14733781 [TBL] [Abstract][Full Text] [Related]
15. Targeted disruption of Smad4 in cardiomyocytes results in cardiac hypertrophy and heart failure. Wang J; Xu N; Feng X; Hou N; Zhang J; Cheng X; Chen Y; Zhang Y; Yang X Circ Res; 2005 Oct; 97(8):821-8. PubMed ID: 16151019 [TBL] [Abstract][Full Text] [Related]
16. Network integration of the adrenergic system in cardiac hypertrophy. Barki-Harrington L; Perrino C; Rockman HA Cardiovasc Res; 2004 Aug; 63(3):391-402. PubMed ID: 15276464 [TBL] [Abstract][Full Text] [Related]
18. Atrial natriuretic peptide inhibits cardiomyocyte hypertrophy through mitogen-activated protein kinase phosphatase-1. Hayashi D; Kudoh S; Shiojima I; Zou Y; Harada K; Shimoyama M; Imai Y; Monzen K; Yamazaki T; Yazaki Y; Nagai R; Komuro I Biochem Biophys Res Commun; 2004 Sep; 322(1):310-9. PubMed ID: 15313208 [TBL] [Abstract][Full Text] [Related]
19. Tales from the crypt: evidence for heptahelical receptor signaling in the endocytic pathway. Whistler J; Beattie E; von Zastrow M Sci STKE; 2000 Aug; 2000(47):pe1. PubMed ID: 11752604 [TBL] [Abstract][Full Text] [Related]
20. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure. Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]